Age‐dependent effects of diabetes and obesity on liver‐related events in non‐alcoholic fatty liver disease: Subanalysis of CLIONE in Asia
Background and Aim Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver‐related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non‐alcoholic fatty liver disease (NAFLD). Methods We performed a suban...
Saved in:
Published in | Journal of gastroenterology and hepatology Vol. 37; no. 12; pp. 2313 - 2320 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Australia
Wiley Subscription Services, Inc
01.12.2022
|
Subjects | |
Online Access | Get full text |
ISSN | 0815-9319 1440-1746 1440-1746 |
DOI | 10.1111/jgh.16019 |
Cover
Abstract | Background and Aim
Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver‐related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non‐alcoholic fatty liver disease (NAFLD).
Methods
We performed a subanalysis of a retrospective cohort study (CLIONE in Asia), including 1395 patients with biopsy‐proven NAFLD. The median follow‐up was 4.6 years.
Results
The median age was 57 years, and 36.2% had T2DM. The median body mass index (BMI) was 27.4, and 28.5% were severely obese (BMI ≥ 30). During follow‐up, 37 patients developed hepatocellular carcinoma (HCC), and 58 patients developed LRE. In patients younger than 65 years, advanced fibrosis (hazard ratio [HR] 7.69, P < 0.001) and T2DM (HR 3.37, P = 0.017) were HCC risk factors, and advanced fibrosis (HR 9.40, P < 0.001) and T2DM (HR 2.51, P = 0.016) were LRE risk factors. In patients 65 years and older, advanced fibrosis (HR 4.24, P = 0.010) and obesity (HR 4.60, P = 0.006) were HCC risk factors, and advanced fibrosis (HR 4.22, P = 0.002) and obesity (HR 4.22, P = 0.002) were LRE risk factors.
Conclusion
Type 2 diabetes mellitus and obesity contributed to LRE in younger and older patients, respectively, along with advanced fibrosis. Therefore, controlling T2DM in patients younger than 65 years and controlling weight in patients 65 years and older could prevent LRE. The development of age‐dependent screening and management strategies is necessary for patients with NAFLD. |
---|---|
AbstractList | Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver-related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non-alcoholic fatty liver disease (NAFLD).BACKGROUND AND AIMOlder age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver-related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non-alcoholic fatty liver disease (NAFLD).We performed a subanalysis of a retrospective cohort study (CLIONE in Asia), including 1395 patients with biopsy-proven NAFLD. The median follow-up was 4.6 years.METHODSWe performed a subanalysis of a retrospective cohort study (CLIONE in Asia), including 1395 patients with biopsy-proven NAFLD. The median follow-up was 4.6 years.The median age was 57 years, and 36.2% had T2DM. The median body mass index (BMI) was 27.4, and 28.5% were severely obese (BMI ≥ 30). During follow-up, 37 patients developed hepatocellular carcinoma (HCC), and 58 patients developed LRE. In patients younger than 65 years, advanced fibrosis (hazard ratio [HR] 7.69, P < 0.001) and T2DM (HR 3.37, P = 0.017) were HCC risk factors, and advanced fibrosis (HR 9.40, P < 0.001) and T2DM (HR 2.51, P = 0.016) were LRE risk factors. In patients 65 years and older, advanced fibrosis (HR 4.24, P = 0.010) and obesity (HR 4.60, P = 0.006) were HCC risk factors, and advanced fibrosis (HR 4.22, P = 0.002) and obesity (HR 4.22, P = 0.002) were LRE risk factors.RESULTSThe median age was 57 years, and 36.2% had T2DM. The median body mass index (BMI) was 27.4, and 28.5% were severely obese (BMI ≥ 30). During follow-up, 37 patients developed hepatocellular carcinoma (HCC), and 58 patients developed LRE. In patients younger than 65 years, advanced fibrosis (hazard ratio [HR] 7.69, P < 0.001) and T2DM (HR 3.37, P = 0.017) were HCC risk factors, and advanced fibrosis (HR 9.40, P < 0.001) and T2DM (HR 2.51, P = 0.016) were LRE risk factors. In patients 65 years and older, advanced fibrosis (HR 4.24, P = 0.010) and obesity (HR 4.60, P = 0.006) were HCC risk factors, and advanced fibrosis (HR 4.22, P = 0.002) and obesity (HR 4.22, P = 0.002) were LRE risk factors.Type 2 diabetes mellitus and obesity contributed to LRE in younger and older patients, respectively, along with advanced fibrosis. Therefore, controlling T2DM in patients younger than 65 years and controlling weight in patients 65 years and older could prevent LRE. The development of age-dependent screening and management strategies is necessary for patients with NAFLD.CONCLUSIONType 2 diabetes mellitus and obesity contributed to LRE in younger and older patients, respectively, along with advanced fibrosis. Therefore, controlling T2DM in patients younger than 65 years and controlling weight in patients 65 years and older could prevent LRE. The development of age-dependent screening and management strategies is necessary for patients with NAFLD. Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver-related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non-alcoholic fatty liver disease (NAFLD). We performed a subanalysis of a retrospective cohort study (CLIONE in Asia), including 1395 patients with biopsy-proven NAFLD. The median follow-up was 4.6 years. The median age was 57 years, and 36.2% had T2DM. The median body mass index (BMI) was 27.4, and 28.5% were severely obese (BMI ≥ 30). During follow-up, 37 patients developed hepatocellular carcinoma (HCC), and 58 patients developed LRE. In patients younger than 65 years, advanced fibrosis (hazard ratio [HR] 7.69, P < 0.001) and T2DM (HR 3.37, P = 0.017) were HCC risk factors, and advanced fibrosis (HR 9.40, P < 0.001) and T2DM (HR 2.51, P = 0.016) were LRE risk factors. In patients 65 years and older, advanced fibrosis (HR 4.24, P = 0.010) and obesity (HR 4.60, P = 0.006) were HCC risk factors, and advanced fibrosis (HR 4.22, P = 0.002) and obesity (HR 4.22, P = 0.002) were LRE risk factors. Type 2 diabetes mellitus and obesity contributed to LRE in younger and older patients, respectively, along with advanced fibrosis. Therefore, controlling T2DM in patients younger than 65 years and controlling weight in patients 65 years and older could prevent LRE. The development of age-dependent screening and management strategies is necessary for patients with NAFLD. Background and Aim Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver‐related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non‐alcoholic fatty liver disease (NAFLD). Methods We performed a subanalysis of a retrospective cohort study (CLIONE in Asia), including 1395 patients with biopsy‐proven NAFLD. The median follow‐up was 4.6 years. Results The median age was 57 years, and 36.2% had T2DM. The median body mass index (BMI) was 27.4, and 28.5% were severely obese (BMI ≥ 30). During follow‐up, 37 patients developed hepatocellular carcinoma (HCC), and 58 patients developed LRE. In patients younger than 65 years, advanced fibrosis (hazard ratio [HR] 7.69, P < 0.001) and T2DM (HR 3.37, P = 0.017) were HCC risk factors, and advanced fibrosis (HR 9.40, P < 0.001) and T2DM (HR 2.51, P = 0.016) were LRE risk factors. In patients 65 years and older, advanced fibrosis (HR 4.24, P = 0.010) and obesity (HR 4.60, P = 0.006) were HCC risk factors, and advanced fibrosis (HR 4.22, P = 0.002) and obesity (HR 4.22, P = 0.002) were LRE risk factors. Conclusion Type 2 diabetes mellitus and obesity contributed to LRE in younger and older patients, respectively, along with advanced fibrosis. Therefore, controlling T2DM in patients younger than 65 years and controlling weight in patients 65 years and older could prevent LRE. The development of age‐dependent screening and management strategies is necessary for patients with NAFLD. Background and AimOlder age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver‐related events (LREs). We investigated the impacts of T2DM and obesity on LRE according to age in Japanese patients with non‐alcoholic fatty liver disease (NAFLD).MethodsWe performed a subanalysis of a retrospective cohort study (CLIONE in Asia), including 1395 patients with biopsy‐proven NAFLD. The median follow‐up was 4.6 years.ResultsThe median age was 57 years, and 36.2% had T2DM. The median body mass index (BMI) was 27.4, and 28.5% were severely obese (BMI ≥ 30). During follow‐up, 37 patients developed hepatocellular carcinoma (HCC), and 58 patients developed LRE. In patients younger than 65 years, advanced fibrosis (hazard ratio [HR] 7.69, P < 0.001) and T2DM (HR 3.37, P = 0.017) were HCC risk factors, and advanced fibrosis (HR 9.40, P < 0.001) and T2DM (HR 2.51, P = 0.016) were LRE risk factors. In patients 65 years and older, advanced fibrosis (HR 4.24, P = 0.010) and obesity (HR 4.60, P = 0.006) were HCC risk factors, and advanced fibrosis (HR 4.22, P = 0.002) and obesity (HR 4.22, P = 0.002) were LRE risk factors.ConclusionType 2 diabetes mellitus and obesity contributed to LRE in younger and older patients, respectively, along with advanced fibrosis. Therefore, controlling T2DM in patients younger than 65 years and controlling weight in patients 65 years and older could prevent LRE. The development of age‐dependent screening and management strategies is necessary for patients with NAFLD. |
Author | Takahashi, Hirokazu Araki, Asuka Sumida, Yoshio Iwaki, Michihiro Tobita, Hiroshi Masaki, Tsutomu Hayashi, Hideki Arakaki, Shingo Seko, Yuya Ueda, Shinichiro Hyogo, Hideyuki Kawaguchi, Takumi Yamamura, Sakura Sawada, Koji Tomita, Eiichi Fujii, Hideki Itoh, Yoshito Morishita, Asahiro Nakajima, Atsushi Yoneda, Masato Naito, Masafumi Okanoue, Takeshi Yasuda, Satoshi Kamada, Yoshihiro Aishima, Shinichi Yoshida, Yuichi Ono, Masafumi Kawanaka, Miwa Toyoda, Hidenori Noritake, Hidenao Tokushige, Akihiro Kawata, Kazuhito Oeda, Satoshi Munekage, Kensuke Maeshiro, Tatsuji |
Author_xml | – sequence: 1 givenname: Yuya orcidid: 0000-0002-3658-5894 surname: Seko fullname: Seko, Yuya organization: Kyoto Prefectural University of Medicine – sequence: 2 givenname: Miwa surname: Kawanaka fullname: Kawanaka, Miwa organization: Kawasaki Medical School – sequence: 3 givenname: Hideki surname: Fujii fullname: Fujii, Hideki email: o21717h@omu.ac.jp organization: Osaka Metropolitan University – sequence: 4 givenname: Michihiro orcidid: 0000-0002-7650-0699 surname: Iwaki fullname: Iwaki, Michihiro organization: Yokohama City University Graduate School of Medicine – sequence: 5 givenname: Hideki surname: Hayashi fullname: Hayashi, Hideki organization: Gifu Municipal Hospital – sequence: 6 givenname: Hidenori orcidid: 0000-0002-1652-6168 surname: Toyoda fullname: Toyoda, Hidenori organization: Ogaki Municipal Hospital – sequence: 7 givenname: Satoshi surname: Oeda fullname: Oeda, Satoshi organization: Saga University Hospital – sequence: 8 givenname: Hideyuki surname: Hyogo fullname: Hyogo, Hideyuki organization: Life Care Clinic Hiroshima – sequence: 9 givenname: Asahiro orcidid: 0000-0002-0760-3045 surname: Morishita fullname: Morishita, Asahiro organization: Kagawa University – sequence: 10 givenname: Kensuke surname: Munekage fullname: Munekage, Kensuke organization: Kochi Medical School – sequence: 11 givenname: Kazuhito surname: Kawata fullname: Kawata, Kazuhito organization: Hamamatsu University School of Medicine – sequence: 12 givenname: Sakura surname: Yamamura fullname: Yamamura, Sakura organization: Kurume University School of Medicine – sequence: 13 givenname: Koji orcidid: 0000-0002-9708-4786 surname: Sawada fullname: Sawada, Koji organization: Asahikawa Medical University – sequence: 14 givenname: Tatsuji surname: Maeshiro fullname: Maeshiro, Tatsuji organization: University of the Ryukyus Hospital – sequence: 15 givenname: Hiroshi orcidid: 0000-0003-2408-2023 surname: Tobita fullname: Tobita, Hiroshi organization: Shimane University Hospital – sequence: 16 givenname: Yuichi surname: Yoshida fullname: Yoshida, Yuichi organization: Suita Municipal Hospital – sequence: 17 givenname: Masafumi surname: Naito fullname: Naito, Masafumi organization: Suita Municipal Hospital – sequence: 18 givenname: Asuka surname: Araki fullname: Araki, Asuka organization: Shimane University Hospital – sequence: 19 givenname: Shingo surname: Arakaki fullname: Arakaki, Shingo organization: University of the Ryukyus Hospital – sequence: 20 givenname: Takumi orcidid: 0000-0002-7064-4325 surname: Kawaguchi fullname: Kawaguchi, Takumi organization: Kurume University School of Medicine – sequence: 21 givenname: Hidenao surname: Noritake fullname: Noritake, Hidenao organization: Hamamatsu University School of Medicine – sequence: 22 givenname: Masafumi surname: Ono fullname: Ono, Masafumi organization: Kagawa University – sequence: 23 givenname: Tsutomu surname: Masaki fullname: Masaki, Tsutomu organization: Kagawa University – sequence: 24 givenname: Satoshi surname: Yasuda fullname: Yasuda, Satoshi organization: Ogaki Municipal Hospital – sequence: 25 givenname: Eiichi surname: Tomita fullname: Tomita, Eiichi organization: Gifu Municipal Hospital – sequence: 26 givenname: Masato surname: Yoneda fullname: Yoneda, Masato organization: Yokohama City University Graduate School of Medicine – sequence: 27 givenname: Akihiro surname: Tokushige fullname: Tokushige, Akihiro organization: Kagoshima University Graduate School of Medical and Dental Sciences – sequence: 28 givenname: Yoshihiro orcidid: 0000-0001-5485-902X surname: Kamada fullname: Kamada, Yoshihiro organization: Osaka University – sequence: 29 givenname: Hirokazu orcidid: 0000-0002-2374-2889 surname: Takahashi fullname: Takahashi, Hirokazu organization: Saga University Hospital – sequence: 30 givenname: Shinichiro surname: Ueda fullname: Ueda, Shinichiro organization: University of the Ryukyus – sequence: 31 givenname: Shinichi surname: Aishima fullname: Aishima, Shinichi organization: Saga University – sequence: 32 givenname: Yoshio orcidid: 0000-0002-4342-1361 surname: Sumida fullname: Sumida, Yoshio organization: Aichi Medical University – sequence: 33 givenname: Takeshi surname: Okanoue fullname: Okanoue, Takeshi organization: Saiseikai Suita Hospital – sequence: 34 givenname: Yoshito surname: Itoh fullname: Itoh, Yoshito organization: Kyoto Prefectural University of Medicine – sequence: 35 givenname: Atsushi orcidid: 0000-0002-6263-1436 surname: Nakajima fullname: Nakajima, Atsushi organization: Yokohama City University Graduate School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36198983$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc1u3CAYRVGVqJmkXfQFKqRumoUTMMY23Y1G-atGzaLtGmH8kTBiYGpwqtnlDdJn7JOU-ckmatggoXMufNxjdOCDB4Q-UHJG8zpf3N2f0ZpQ8QZNaFWRgjZVfYAmpKW8EIyKI3Qc44IQUpGGv0VHrKaiFS2boKfpHfx9_NPDCnwPPmEwBnSKOBjcW9VBgoiV73HoINq0xsFjZx9gyNIATiXoMTxkMWLrcX5XPldOh_vgrMZGpaxs-ZwWQUX4gr-PnfLKraPd3jKb39x-u9jY02jVO3RolIvwfr-foJ-XFz9m18X89upmNp0XuqqZKMqy05pxbpqOci7Kjuo8OKdU8JpVbQ2GGkVBGda3FW04UGNUr7QpO9ZrztkJ-rzLXQ3h1wgxyaWNGpxTHsIYZdmUJctxpMropxfoIoxDnmBDVY2o67beUB_31NgtoZerwS7VsJbPX52B8x2ghxDjAEZqm1SywadBWScpkZsyZS5TbsvMxukL4zn0f-w-_bd1sH4dlF-vrnfGPyIEsR0 |
CitedBy_id | crossref_primary_10_1186_s12876_023_02848_7 crossref_primary_10_1186_s12916_024_03315_0 crossref_primary_10_1016_j_cgh_2023_11_022 |
Cites_doi | 10.1002/hep.29085 10.1172/JCI45887 10.1002/cncr.24982 10.1002/hep.28431 10.1007/s00535-018-1532-5 10.1158/0008-5472.CAN-06-3075 10.1007/s00592-003-0093-z 10.1016/j.jhep.2017.07.027 10.1016/j.cgh.2018.05.057 10.1007/s12072-021-10143-4 10.1007/s40618-016-0508-7 10.1210/er.2011-1015 10.1007/s00535-015-1050-7 10.1002/hep.32244 10.1136/gutjnl-2020-322786 10.1016/j.jhep.2019.06.021 10.1002/hep.31014 10.1016/S0140-6736(03)15268-3 10.1056/NEJMoa2029349 10.1002/hep.20701 10.1016/j.jhepr.2021.100305 10.1038/sj.bjc.6603932 10.1002/hep.25762 10.1016/j.ejca.2012.02.063 10.1053/j.gastro.2015.04.043 10.1136/gut.2009.199661 |
ContentType | Journal Article |
Copyright | 2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. 2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd |
Copyright_xml | – notice: 2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. – notice: 2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd |
CorporateAuthor | Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG‐NAFLD) Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD) |
CorporateAuthor_xml | – name: Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG‐NAFLD) – name: Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD) |
DBID | AAYXX CITATION NPM 7T5 7U9 H94 K9. 7X8 |
DOI | 10.1111/jgh.16019 |
DatabaseName | CrossRef PubMed Immunology Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1440-1746 |
EndPage | 2320 |
ExternalDocumentID | 36198983 10_1111_jgh_16019 JGH16019 |
Genre | article Journal Article |
GeographicLocations | Asia |
GeographicLocations_xml | – name: Asia |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OB 1OC 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHEFC AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F D-I DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DTERQ DU5 EBS EJD EMOBN ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO KMS LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOQ WOW WQJ WRC WUP WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION NPM 7T5 7U9 AAMMB AEFGJ AGXDD AIDQK AIDYY H94 K9. 7X8 |
ID | FETCH-LOGICAL-c4639-22bcc355f7b15592b1c1445119563486ef1fa1eaf3d84175e1ffadacf2b3dc553 |
IEDL.DBID | DR2 |
ISSN | 0815-9319 1440-1746 |
IngestDate | Thu Sep 04 16:40:08 EDT 2025 Wed Aug 13 06:24:55 EDT 2025 Wed Feb 19 02:26:33 EST 2025 Tue Jul 01 01:45:28 EDT 2025 Thu Apr 24 23:05:46 EDT 2025 Wed Jan 22 16:22:23 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | CLIONE in Asia non-alcoholic fatty liver disease type 2 diabetes mellitus liver-related events fibrosis age hepatocellular carcinoma obesity BMI non-alcoholic steatohepatitis |
Language | English |
License | 2022 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4639-22bcc355f7b15592b1c1445119563486ef1fa1eaf3d84175e1ffadacf2b3dc553 |
Notes | No funding support to this study. The authors do not have any disclosures to report. Ethical approval Declaration of conflict of interest This multicenter registry‐based historical cohort study was approved by the institutional review board of Saga University Hospital, Saga, Japan (approval no. 2020‐04‐R‐02; June 30, 2020), which waived the requirement for informed consent due to the use of preexisting data. Financial support ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-9708-4786 0000-0002-3658-5894 0000-0002-7064-4325 0000-0002-2374-2889 0000-0002-1652-6168 0000-0002-0760-3045 0000-0002-7650-0699 0000-0002-6263-1436 0000-0001-5485-902X 0000-0003-2408-2023 0000-0002-4342-1361 |
OpenAccessLink | https://ocu-omu.repo.nii.ac.jp/records/2019978 |
PMID | 36198983 |
PQID | 2747966864 |
PQPubID | 2045136 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_2722311904 proquest_journals_2747966864 pubmed_primary_36198983 crossref_citationtrail_10_1111_jgh_16019 crossref_primary_10_1111_jgh_16019 wiley_primary_10_1111_jgh_16019_JGH16019 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2022 |
PublicationDateYYYYMMDD | 2022-12-01 |
PublicationDate_xml | – month: 12 year: 2022 text: December 2022 |
PublicationDecade | 2020 |
PublicationPlace | Australia |
PublicationPlace_xml | – name: Australia – name: Richmond |
PublicationTitle | Journal of gastroenterology and hepatology |
PublicationTitleAlternate | J Gastroenterol Hepatol |
PublicationYear | 2022 |
Publisher | Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc |
References | 2004; 363 2019; 71 2010; 59 2021; 3 2015; 149 2015; 50 2019; 54 2017; 65 2017; 67 2019; 17 2005; 41 2021; 385 2007; 97 2016; 39 2012; 55 2012; 33 2021; 70 2021; 15 2022 2010; 116 2020; 71 2016; 64 2022; 75 2012; 48 2003; 40 2007; 67 2011; 121 e_1_2_6_10_1 e_1_2_6_19_1 e_1_2_6_13_1 e_1_2_6_14_1 e_1_2_6_12_1 e_1_2_6_17_1 e_1_2_6_18_1 e_1_2_6_15_1 e_1_2_6_16_1 e_1_2_6_21_1 e_1_2_6_20_1 e_1_2_6_9_1 Fujii H (e_1_2_6_11_1) 2022 e_1_2_6_8_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_28_1 e_1_2_6_27_1 e_1_2_6_26_1 |
References_xml | – volume: 71 start-page: 808 year: 2020 end-page: 819 article-title: Effect of metabolic traits on the risk of cirrhosis and hepatocellular cancer in nonalcoholic fatty liver disease publication-title: Hepatology – volume: 116 start-page: 1938 year: 2010 end-page: 1946 article-title: Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma publication-title: Cancer – volume: 40 start-page: S302 year: 2003 end-page: S304 article-title: Ethnic differences in abdominal visceral fat accumulation between Japanese, African‐Americans, and Caucasians: a meta‐analysis publication-title: Acta Diabetol. – volume: 75 start-page: 1420 year: 2022 end-page: 1428 article-title: Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with nonalcoholic fatty liver disease publication-title: Hepatology – volume: 41 start-page: 1313 year: 2005 end-page: 1321 article-title: Design and validation of a histological scoring system for nonalcoholic fatty liver disease publication-title: Hepatology – volume: 67 start-page: 1265 year: 2017 end-page: 1273 article-title: Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy‐proven NAFLD publication-title: J. Hepatol. – volume: 17 start-page: 748 year: 2019 end-page: 755.e743 article-title: Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates publication-title: Clin. Gastroenterol. Hepatol. – volume: 64 start-page: 73 year: 2016 end-page: 84 article-title: Global epidemiology of nonalcoholic fatty liver disease—meta‐analytic assessment of prevalence, incidence, and outcomes publication-title: Hepatology – volume: 385 start-page: 1559 year: 2021 end-page: 1569 article-title: Prospective study of outcomes in adults with nonalcoholic fatty liver disease publication-title: N. Engl. J. Med. – volume: 65 start-page: 1557 year: 2017 end-page: 1565 article-title: Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis publication-title: Hepatology – volume: 54 start-page: 367 year: 2019 end-page: 376 article-title: A nationwide survey on non‐B, non‐C hepatocellular carcinoma in Japan: 2011–2015 update publication-title: J. Gastroenterol. – volume: 33 start-page: 547 year: 2012 end-page: 594 article-title: The role of adiponectin in cancer: a review of current evidence publication-title: Endocr. Rev. – volume: 121 start-page: 2094 year: 2011 end-page: 2101 article-title: Adipose tissue remodeling and obesity publication-title: J. Clin. Invest. – volume: 67 start-page: 2497 year: 2007 end-page: 2507 article-title: Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin‐mediated promotion of invasion and migration of hepatocellular carcinoma cells publication-title: Cancer Res. – volume: 97 start-page: 1005 year: 2007 end-page: 1008 article-title: Overweight, obesity and risk of liver cancer: a meta‐analysis of cohort studies publication-title: Br. J. Cancer – volume: 70 start-page: 1375 year: 2021 end-page: 1382 article-title: Mortality in biopsy‐confirmed nonalcoholic fatty liver disease: results from a nationwide cohort publication-title: Gut – volume: 55 start-page: 2005 year: 2012 end-page: 2023 article-title: The diagnosis and management of non‐alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association publication-title: Hepatology – volume: 71 start-page: 793 year: 2019 end-page: 801 article-title: The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta‐analysis publication-title: J. Hepatol. – volume: 48 start-page: 2137 year: 2012 end-page: 2145 article-title: Excess body weight and the risk of primary liver cancer: an updated meta‐analysis of prospective studies publication-title: Eur. J. Cancer – volume: 149 start-page: 389 year: 2015 end-page: 397 article-title: Liver fibrosis, but no other histologic features, is associated with long‐term outcomes of patients with nonalcoholic fatty liver disease publication-title: Gastroenterology – volume: 50 start-page: 364 year: 2015 end-page: 377 article-title: Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis publication-title: J. Gastroenterol. – volume: 39 start-page: 1365 year: 2016 end-page: 1376 article-title: Insulin, insulin receptors, and cancer publication-title: J. Endocrinol. Invest. – volume: 3 year: 2021 article-title: Epidemiology of non‐alcoholic fatty liver disease and hepatocellular carcinoma publication-title: JHEP Rep. – volume: 15 start-page: 366 year: 2021 end-page: 379 article-title: The epidemiology of NAFLD and lean NAFLD in Japan: a meta‐analysis with individual and forecasting analysis, 1995–2040 publication-title: Hepatol. Int. – volume: 59 start-page: 1303 year: 2010 end-page: 1307 article-title: Non‐alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications publication-title: Gut – volume: 363 start-page: 157 year: 2004 end-page: 163 article-title: Appropriate body‐mass index for Asian populations and its implications for policy and intervention strategies publication-title: Lancet – year: 2022 article-title: Clinical outcomes in biopsy‐proven nonalcoholic fatty liver disease patients: a multicenter registry‐based cohort study publication-title: Clin. Gastroenterol. Hepatol. – ident: e_1_2_6_15_1 doi: 10.1002/hep.29085 – ident: e_1_2_6_24_1 doi: 10.1172/JCI45887 – ident: e_1_2_6_18_1 doi: 10.1002/cncr.24982 – ident: e_1_2_6_4_1 doi: 10.1002/hep.28431 – ident: e_1_2_6_8_1 doi: 10.1007/s00535-018-1532-5 – ident: e_1_2_6_23_1 doi: 10.1158/0008-5472.CAN-06-3075 – ident: e_1_2_6_27_1 doi: 10.1007/s00592-003-0093-z – ident: e_1_2_6_7_1 doi: 10.1016/j.jhep.2017.07.027 – ident: e_1_2_6_13_1 doi: 10.1016/j.cgh.2018.05.057 – ident: e_1_2_6_10_1 doi: 10.1007/s12072-021-10143-4 – ident: e_1_2_6_17_1 doi: 10.1007/s40618-016-0508-7 – ident: e_1_2_6_25_1 doi: 10.1210/er.2011-1015 – ident: e_1_2_6_3_1 doi: 10.1007/s00535-015-1050-7 – ident: e_1_2_6_28_1 doi: 10.1002/hep.32244 – ident: e_1_2_6_14_1 doi: 10.1136/gutjnl-2020-322786 – ident: e_1_2_6_9_1 doi: 10.1016/j.jhep.2019.06.021 – ident: e_1_2_6_16_1 doi: 10.1002/hep.31014 – ident: e_1_2_6_26_1 doi: 10.1016/S0140-6736(03)15268-3 – ident: e_1_2_6_5_1 doi: 10.1056/NEJMoa2029349 – ident: e_1_2_6_12_1 doi: 10.1002/hep.20701 – ident: e_1_2_6_21_1 doi: 10.1016/j.jhepr.2021.100305 – ident: e_1_2_6_19_1 doi: 10.1038/sj.bjc.6603932 – ident: e_1_2_6_2_1 doi: 10.1002/hep.25762 – start-page: S1542‐3565(22)0 year: 2022 ident: e_1_2_6_11_1 article-title: Clinical outcomes in biopsy‐proven nonalcoholic fatty liver disease patients: a multicenter registry‐based cohort study publication-title: Clin. Gastroenterol. Hepatol. – ident: e_1_2_6_20_1 doi: 10.1016/j.ejca.2012.02.063 – ident: e_1_2_6_6_1 doi: 10.1053/j.gastro.2015.04.043 – ident: e_1_2_6_22_1 doi: 10.1136/gut.2009.199661 |
SSID | ssj0004075 |
Score | 2.3996565 |
Snippet | Background and Aim
Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver‐related events (LREs). We investigated the impacts... Older age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver-related events (LREs). We investigated the impacts of T2DM and obesity... Background and AimOlder age, type 2 diabetes mellitus (T2DM), and obesity are known risk factors for liver‐related events (LREs). We investigated the impacts... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2313 |
SubjectTerms | Age Biopsy BMI Body mass index CLIONE in Asia Diabetes Diabetes mellitus (non-insulin dependent) Fatty liver Fibrosis Hepatocellular carcinoma Liver cancer Liver diseases liver‐related events non‐alcoholic fatty liver disease non‐alcoholic steatohepatitis Obesity Risk factors type 2 diabetes mellitus |
Title | Age‐dependent effects of diabetes and obesity on liver‐related events in non‐alcoholic fatty liver disease: Subanalysis of CLIONE in Asia |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjgh.16019 https://www.ncbi.nlm.nih.gov/pubmed/36198983 https://www.proquest.com/docview/2747966864 https://www.proquest.com/docview/2722311904 |
Volume | 37 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwELYQB9RLebVlC0Wm6qGXIGI73oSeVgt0hdoeqiJxqBT5ubsCJRWbvXDiH8Bv5JcwfiR0W5Cq3qJkHNvJjP2NPf4GoQ-GsKzQRifEZTVhRBWJYIwmWukDq7jkPET5fuOjM3Z6np0voU_tWZjAD9EtuDnL8OO1M3AhZ78b-XjilkY85WdKuePNP_r-SB3FAskuzHhZUoCeRVYhH8XTllyci_4CmIt41U84J6voZ9vUEGdysT9v5L66_oPF8T_7soZeRiCKB0Fz1tGSqTbQyte41b6Jbgdjc39z1ybJbXCM_MC1xe2CLRaVxnVILYDrCl-6IA8o5A_IGI09O9QMTytc1RXcFyEf71RhKxoo4uVx3CM6xDCIiciR4moZfoFx_tiVHsym4hU6Ozn-MRwlMXtDohjAnoQQqRSgGduXbuuTyFSlng0NPDLKcm5sakVqhKU6ZwBiTGqt0EJZIqlWWUZfo2VonNlCuOAaYA3XQsMb-pTIPrhBuSiI0lywPumhj-1_LFWkNncZNi7LzsUZT0r_gXvofSf6K_B5PCW00ypDGU16Vjr3HXzDnLMe2usegzG6HRZRmXruZABtQQ8PQOZNUKKuFspdeFpOobFeFZ6vvjz9PPIXb_9ddBu9IO5ghg-02UHLzdXcvAO41MhdbxcPmZkS9w |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRQIuvB8LBQziwCVV4zjeBHFZlZalbHtArdQLihw_tiuqpOpmL5z4B_Ab-SXM2E6gPCTELUrGsZ3M2N_Y428Anlsu8tJYk3DKaiK4LhMlRJYYbbaclrWUIcr3QE6PxN5xfrwGr_qzMIEfYlhwI8vw4zUZOC1I_2zl8xNaGyHOz0sCgQa5Xq_f_yCPEoFmF-e8PClR0yKvkI_j6YtenI1-g5gXEaufcnavw4e-sSHS5OPmqqs39adfeBz_tzc34FrEomwSlOcmrNnmFlzej7vtt-HLZG6_ff7a58ntWAz-YK1j_ZotU41hbcguwNqGnVKcBxbyZ2SsYZ4gaskWDWvaBu-rkJJ3oZlTHRbx8ixuE71kOI6pSJNCtWzPcKjfodKT5ULdgaPdncPtaRITOCRaIPJJOK-1RkDjxjXtfvI61aknREOnLBOFtC51KrXKZaYQiGNs6pwySjteZ0bneXYX1rFx9j6wUhpENtIog28YZ7weoydUqJJrI5UY8xG86H9kpSO7OSXZOK0GL2d-UvkPPIJng-hZoPT4k9BGrw1VtOplRR48uoeFFCN4OjxGe6RNFtXYdkUyCLiwh1socy9o0VBLJilCrciwsV4X_l59tfdm6i8e_LvoE7gyPdyfVbO3B-8ewlVO5zR83M0GrHfnK_sI0VNXP_ZG8h25mxcW |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB4hKiEufQBtt9DiVhx6CSKO403oaUVZlkcRQkXiUCly_FhWRQlis5ee-g_ob-wv6fiRtDwqVb1FyTi2kxn7G3v8DcCGpizNlVYRtVlNGJV5JBhLIiXVlpG85NxH-R7z0Rk7OE_P5-BDexbG80N0C27WMtx4bQ38Spk_jXx8YZdGLOXnI8YRSVhEdPqbO4p5ll2c8tIoR0ULtEIujKctensyuocwbwNWN-MMn8CXtq0-0OTr5qwpN-W3OzSO_9mZp_A4IFEy8KrzDOZ0tQQLn8Je-zLcDMb65_cfbZbchoTQD1Ib0q7YElEpUvvcAqSuyKWN8sBC7oSMVsTRQ03JpCJVXeF94RPyTiQxosEiTp6ETaJtgqOYCCQptpadIxzod23pwXQiVuBsuPt5ZxSF9A2RZIh7IkpLKRHOmH5p9z5pGcvY0aGhS5awjGsTGxFrYRKVMUQxOjZGKCENLRMl0zR5DvPYOP0SSM4V4hquhMI39BNa9tEPykROpeKC9WkP3rf_sZCB29ym2LgsOh9nfFG4D9yDd53olSf0eEhorVWGItj0tLD-OzqHGWc9eNs9Rmu0Wyyi0vXMyiDcwh5uocwLr0RdLQm38WlZgo11qvD36ouDvZG7ePXvouuwcPJxWBztHx-uwiK1hzRc0M0azDfXM_0aoVNTvnEm8gttQBXF |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Age%E2%80%90dependent+effects+of+diabetes+and+obesity+on+liver%E2%80%90related+events+in+non%E2%80%90alcoholic+fatty+liver+disease%3A+Subanalysis+of+CLIONE+in+Asia&rft.jtitle=Journal+of+gastroenterology+and+hepatology&rft.au=Seko%2C+Yuya&rft.au=Kawanaka%2C+Miwa&rft.au=Fujii%2C+Hideki&rft.au=Iwaki%2C+Michihiro&rft.date=2022-12-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0815-9319&rft.eissn=1440-1746&rft.volume=37&rft.issue=12&rft.spage=2313&rft.epage=2320&rft_id=info:doi/10.1111%2Fjgh.16019&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0815-9319&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0815-9319&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0815-9319&client=summon |